Cargando…
The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582594/ https://www.ncbi.nlm.nih.gov/pubmed/34747190 http://dx.doi.org/10.2217/imt-2021-0235 |
_version_ | 1784597023785222144 |
---|---|
author | Malek, Alexandre E Cornejo, Paulette Pinargote Daoud, Nour Alam, Mohammad |
author_facet | Malek, Alexandre E Cornejo, Paulette Pinargote Daoud, Nour Alam, Mohammad |
author_sort | Malek, Alexandre E |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8582594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Future Medicine Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-85825942021-11-12 The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't Malek, Alexandre E Cornejo, Paulette Pinargote Daoud, Nour Alam, Mohammad Immunotherapy Editorial Future Medicine Ltd 2021-11-08 2021-10 /pmc/articles/PMC8582594/ /pubmed/34747190 http://dx.doi.org/10.2217/imt-2021-0235 Text en © 2021 Future Medicine Ltd https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Editorial Malek, Alexandre E Cornejo, Paulette Pinargote Daoud, Nour Alam, Mohammad The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't |
title | The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't |
title_full | The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't |
title_fullStr | The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't |
title_full_unstemmed | The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't |
title_short | The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't |
title_sort | mrna covid-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582594/ https://www.ncbi.nlm.nih.gov/pubmed/34747190 http://dx.doi.org/10.2217/imt-2021-0235 |
work_keys_str_mv | AT malekalexandree themrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont AT cornejopaulettepinargote themrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont AT daoudnour themrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont AT alammohammad themrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont AT malekalexandree mrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont AT cornejopaulettepinargote mrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont AT daoudnour mrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont AT alammohammad mrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont |